Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from diabetes

WHO Backs Weight-loss Drugs, Urges Cheap Generics

The World Health Organization recommended a range of blockbuster weight-loss drugs to treat diabetes and obesity globally for the first time on Friday, calling for cheap generic versions to be made available for people in developing countries.

International Business Times

Error means 55,000 patients require diabetes retests after potential misdiagnoses

More than 55,000 patients may require new blood tests to receive an accurate blood glucose reading

The Independent UK

‘Artificial pancreas’ to be given to women with diabetes to cut pregnancy risks

Mothers-to-be with the condition have higher risks as pregnancy hormones can make it harder for them to regulate their blood glucose levels.

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

New technology for diabetic pregnant women will reduce risk of miscarriage and stillbirth

The new technology, known as a hybrid closed loop system, will help reduce the risk of stillbirth and miscarriage

The Independent UK

From Diagnosis to Advocacy: How Dr. Keith Hersey is Guiding Patients Through Diabetes and GLP-1 Therapy

Hersey is slated to speak at an international conference in Orlando and will address a local diabetes support group in Raleigh on October 1.

International Business Times

RFK Jr, who doesn’t have a medical degree, says he can diagnose children just by just looking at them

Kennedy has often raised concerns about the increasing juvenile diabetes and autism rates

The Independent UK

UK Patients Scramble For Mounjaro As Eli Lilly's 170% Price Hike Plan Sparks Shortages, Health Fears

Patients across the United Kingdom are struggling to obtain the weight-loss and diabetes drug Mounjaro as demand surges ahead of a sharp price increase set for September.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Daily weight loss pill achieves main goal in late-stage trial

Data from an earlier study of the drug in patients without diabetes sent company shares tumbling

The Independent UK

Eli Lilly's Obesity Pill Shows Big Wins In Weight, Blood Sugar And Heart Risk Factors

Eli Lilly and Co. (NYSE:LLY) on Tuesday released topline results from the Phase 3 ATTAIN-2 trial, evaluating oral orforglipron in adults with obesity or overweight and type 2 diabetes.

Benzinga

Diabetes smartphone test could diagnose condition in under 10 minutes

The creators of the world-first app at diagnostics company PocDoc say the test could also save the NHS billions

The Independent UK

UK firms misleading parents with milk teeth autism treatment claims, report finds

Charity says it is ‘outrageous’ tooth stem cell procedures are being advertised with claims about ‘treating’ autism

The Guardian - UK

Exclusive: Twin Health, metabolic health startup, raises $53 million Series E at $950 million valuation

Twin Health raised a $53 million Series E led by Maj Invest of Denmark, Fortune has exclusively learned.

Fortune

The supplement that could help with weight loss for people with diabetes

Turmeric and curcumin may offer modest benefits for weight management in people with prediabetes and type 2 diabetes, a new study found

The Independent UK

Type 2 diabetes patients set for major shake-up in care

New draft guidance from the National Institute for Health and Care Excellence suggests the NHS should move away from a one-size-fits-all approach.

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Diabetes patients could be offered weight loss jabs sooner in major shake-up

The changes will impact millions of people with type 2 diabetes in England in the biggest shake-up of care in a decade

Benzinga

Ozempic Gains First Approval In Canada For Kidney Disease And Cardiovascular Death Risk

Health Canada on Tuesday approved Novo Nordisk's (NYSE:NVO) Ozempic (semaglutide) to reduce the risk of kidney disease and cardiovascular deaths in adults with type 2 diabetes.

The Guardian - AU

Continuous glucose monitors: should people who don’t live with diabetes be wearing them?

Gwyneth Paltrow and other celebrities and influencers are sporting CGMs, but counting your glucose levels provides little benefit if you don’t have diabetes

The Independent UK

Half-off Ozempic? US patients paying in cash can now buy the popular weight-loss drug for less

The drug is available as a weight-loss medication under the brand name Wegovy and will now also be sold directly to diabetes patients

Get all your
news in one place.

100's of premium titles.
One news app.

Fortune

Novo Nordisk slashes price of Ozempic in half to $499 for cash-paying, eligible U.S. patients

The previous out-of-pocket price was nearly $1,000.

The Independent UK

New study finally busts health myth of much-loved tropical fruit

Clinical trials replaced breakfast bread with a mango and monitored glycemic responses

Benzinga

Novo Nordisk's Lead Fades, Eli Lilly Holds Course For Outsized Gains, Says Analyst

On Thursday, Eli Lilly and Co. (NYSE:LLY) said it will sharply increase the list price of its weight-loss and type 2 diabetes drug Mounjaro (tirzepatide) in the United Kingdom.

International Business Times UK

Mounjaro Is About to Get More Expensive in the UK: Here Are Cheaper Alternatives Available Right Now

Mounjaro's UK price will rise by 170% in September, prompting interest in cheaper alternatives like semaglutide for weight loss.

The Guardian - US

Ozempic didn’t work for me. I was furious – and ashamed

Everyone taking the ‘skinny shot’ was losing weight, but my scales didn’t change. My inner dialogue became toxic

The Independent UK

Breakthrough drug that slows onset of type 1 diabetes set for UK release

Teplizumab can allow patients to live “normal lives” without the need for insulin injections

Evening Standard

Drug that slows onset of type 1 diabetes licensed for use in UK-first

The cost-effectiveness of the drug for NHS roll-out will now be assessed by the National Institute for Health and Care Excellence.

1 … 19 20 21 22

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the World Health Organization

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.